Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced/Metastatic Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03555032
What this trial is testing

TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion)

Who this might be right for
Melanoma and Sarcoma
Royal Marsden NHS Foundation Trust 15
Testing effectiveness (Phase 2)UnknownNCT05318339
What this trial is testing

Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional CellHER-2 Gene Amplification
Chinese Academy of Medical Sciences 30
Large-scale testing (Phase 3)Study completedNCT03766295
What this trial is testing

Masitinib Plus Gemcitabine in Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
AB Science 377
Testing effectiveness (Phase 2)Looking for participantsNCT06341595
What this trial is testing

Concurrent Chemoradiotherapy Combined With Sintilimab as Neoadjuvant Therapy for GC Patients With PALM

Who this might be right for
Gastric CancerGastric Cancer Metastatic to Regional Lymph Nodes
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04180501
What this trial is testing

SRS Sequential Sindilimab in Brain Metastasis of NSLSC

Who this might be right for
NSCLC Stage IVBrain MetastasesSRS+1 more
Xiaorong Dong 25
Large-scale testing (Phase 3)Looking for participantsNCT06956001
What this trial is testing

Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With EGFR PACC or EGFR l861q Mutation

Who this might be right for
EGFRNSCLC (Advanced Non-small Cell Lung Cancer)
Allist Pharmaceuticals, Inc. 300
Testing effectiveness (Phase 2)UnknownNCT05952128
What this trial is testing

Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 50
Not applicableStudy completedNCT05032092
What this trial is testing

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

Who this might be right for
Locally Advanced CarcinomaMetastatic Cancer
Medical University of Graz 235
Testing effectiveness (Phase 2)Looking for participantsNCT05475171
What this trial is testing

Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)

Who this might be right for
Metastatic CancerCervical Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)WithdrawnNCT05251038
What this trial is testing

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more
Devalingam Mahalingam
Early research (Phase 1)Ended earlyNCT01991938
What this trial is testing

Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

Who this might be right for
Non Hematologic CancersMetastatic CancerLymphoma
Verastem, Inc. 75
Early research (Phase 1)Study completedNCT01487785
What this trial is testing

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05445843
What this trial is testing

Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

Who this might be right for
Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
Novartis Pharmaceuticals 95
Testing effectiveness (Phase 2)Ended earlyNCT02580708
What this trial is testing

Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Not applicableNo Longer AvailableNCT05511350
What this trial is testing

Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001

Who this might be right for
Solid Tumor Metastatic Cancer Advanced Cancer
I-Mab Biopharma US Limited
Testing effectiveness (Phase 2)Active Not RecruitingNCT02955290
What this trial is testing

CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaLung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell Carcinoma+13 more
Roswell Park Cancer Institute 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Early research (Phase 1)Study completedNCT01213238
What this trial is testing

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT06226350
What this trial is testing

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 29
Next Page